Per Norlén

Orexin loss in Huntington's disease

Åsa Petersén, Joana Gil‐Mohapel, Marion L. C. Maat–Schieman et al. · Human Molecular Genetics · 2004 · 270 citations

Life Sciences, Neurology, Neuroscience +16

Ghrelin stimulates gastric emptying but is without effect on acid secretion and gastric endocrine cells

Charlotta Dornonville de la Cour, Erik Lindström, Per Norlén et al. · Regulatory Peptides · 2004 · 169 citations

Life Sciences, Endocrinology, Physiology +13

First‐in‐human study with intratumoral administration of a CD40 agonistic antibody, ADC‐1013, in advanced solid malignancies

Sandra Irenaeus, Dorte Nielsen, Peter Ellmark et al. · International Journal of Cancer · 2019 · 142 citations

Medicine, Oncology, Pharmacology +16

Progressive alterations in the hypothalamic-pituitary-adrenal axis in the R6/2 transgenic mouse model of Huntington's disease

Maria Björkqvist, Åsa Petersén, Karl Bacos et al. · Human Molecular Genetics · 2006 · 140 citations · Full text

Medicine, Endocrinology, Neurology +17

The CTLA-4 x OX40 bispecific antibody ATOR-1015 induces anti-tumor effects through tumor-directed immune activation

Anne Månsson Kvarnhammar, Niina Veitonmäki, Karin Hägerbrand et al. · Journal for ImmunoTherapy of Cancer · 2019 · 114 citations · Full text

Medicine, Immunology, Oncology +17